Joachim Beck

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

Bob Löwenberg, Gert J. Ossenkoppele, Wim van Putten et al. · New England Journal of Medicine · 2009 · 822 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation

Nicola Gökbuget, Daniel Stanze, Joachim Beck et al. · Blood · 2012 · 465 citations · Full text

Medicine, Hematology, Oncology +14

A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients with Refractory Hematologic Malignancies

Francis J. Giles, Thomas Fischer, Jörge E. Cortes et al. · Clinical Cancer Research · 2006 · 314 citations

Medicine, Hematology, Pharmacology +17

Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma

Leigh Ellis, Yan Pan, Gordon K. Smyth et al. · Clinical Cancer Research · 2008 · 300 citations

Medicine, Oncology, Pharmacology +17

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

Dieter Hoelzer, Jan Walewski, Hartmut Döhner et al. · Blood · 2014 · 297 citations · Full text

Medicine, Oncology, Pharmacotherapy +13